Laurus Labs is currently trading at Rs. 507.45, up by 0.85 points or 0.17% from its previous closing of Rs. 506.60 on the BSE.
The scrip opened at Rs. 503.50 and has touched a high and low of Rs. 507.45 and Rs. 503.50 respectively.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 634.00 on 12-Jun-2017 and a 52 week low of Rs. 485.00 on 05-Feb-2018.
Last one week high and low of the scrip stood at Rs. 529.75 and Rs. 503.50 respectively. The current market cap of the company is Rs. 5,380.00 crore.
The promoters holding in the company stood at 30.57%, while Institutions and Non-Institutions held 50.60% and 18.83% respectively.
Laurus Labs has successfully completed the US Food and Drug Administration (USFDA) audit without observations - ZERO 483 for its Unit 2 (formulations unit). The inspection was carried out from February 26, 2018 to March 1, 2018.
Besides, the company has also received its maiden Approval from USFDA for Tenofovir Disoproxil Fumarate Tablets 300mg. Tenofovir Disoproxil Fumarate Tablets 300mg is therapeutically equivalent to VIREAD Tablets 300mg of Gilead Science. Tenofovir Disoproxil Fumarate Tablets 300mg is used for treatment of HIV-1 infection in adults and paediatric patients 2 years of age and older.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1748.60 |
| Dr. Reddys Lab | 1164.70 |
| Cipla | 1508.70 |
| Lupin | 2035.30 |
| Zydus Lifesciences | 903.10 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
100% Secure Process
Account Discovery
- OTP from CAMS
Account Linking for Stocks & MF
- One OTP per link Eg. NSDL, CDSL, CAMS, KFin etc.
One Click Upload for your Current Portfolio and Future Transactions!
Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
